- 专利标题： INTRANASAL PHARMACEUTICAL COMPOSITIONS OF CYCLOBENZAPRINE
-
申请号： US17765030申请日： 2020-09-30
-
公开(公告)号： US20220339124A1公开(公告)日： 2022-10-27
- 发明人: Kannan Essakimuthu MUTHAIYYAN , Ritu Nitin LADDHA , Harish PAWAR , Shailesh Arvindbhai PATEL , Jay Shantilal KOTHARI
- 申请人： CADILA HEALTHCARE LIMITED
- 申请人地址： IN Ahmedabad, Gujarat
- 专利权人： CADILA HEALTHCARE LIMITED
- 当前专利权人： CADILA HEALTHCARE LIMITED
- 当前专利权人地址： IN Ahmedabad, Gujarat
- 优先权： IN201921039492 20190930
- 国际申请： PCT/IB2020/059144 WO 20200930
- 主分类号： A61K31/135
- IPC分类号： A61K31/135 ; A61K9/00 ; A61K9/08
摘要：
The present invention relates to intranasal pharmaceutical compositions comprising cyclobenzaprine or salts thereof for the treatment or management of muscle spasms in musculoskeletal diseases and/or painful physical symptoms in neurological diseases. In particular, the invention relates to intranasal pharmaceutical compositions comprising cyclobenzaprine or salts thereof and one or more pharmaceutically acceptable excipients.
信息查询
